The National Council on Compensation Insurance (NCCI) released its latest Labor Market Insights report, offering a snapshot of current employment trends and their potential impact on workers’ compensation. By highlighting...
...use data from a comparator product approved outside the U.S. as evidence that a proposed product is biosimilar to the U.S.-licensed product. The recommendations describe scenarios in which a biosimilar...
Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...
...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
...increased dramatically since AMA’s last survey, with nearly 40% of respondents using it within workflows – 26 percentage points higher than 2024. Physician sentiment toward AI continues to trend positive....
Healthesystems’ VP of Clinical Services, Silvia Sacalis, BS, PharmD, was featured in the International Association of Industrial Accident Boards and Commissions’ (IAIABC) Perspectives publication. Dr. Sacalis penned an article on...
Hawaii House Bill 2387 was introduced, which would expand the currently existing cancer presumption for firefighters, and cover additional types of cancer under workers’ comp. For firefighters with five or...
Healthesystems' Advocacy and Compliance team recently attended the NCCI Annual Insights Symposium in Orlando, Florida. This event brings together executive leaders and actuaries from the workers' compensation industry to hear...
Risk and Insurance magazine published a new article that explores how AI can enhance workers’ compensation by automating mundane tasks, allowing adjusters to focus human expertise on complex claims and...
...drug would be the first oral antiviral medication for COVID-19. For all of the latest updates on FDA drug approvals impacting workers’ comp, check out our interactive web tool, MedMonitor....
...populations include healthcare workers. Recently, ViiV Healthcare, a GlaxoSmithKline company, communicated to the FDA that several HIV medications they manufacture will be discontinued by the end of 2023. While many...
...care under A.R.S. § 23 1070 would remain unchanged. Additionally, the bill clarifies that initial compensation payments must be made no later than the 21st day after the Industrial Commission...
...for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for the treatment of PTSD. While this has been long coming, with the FDA...
...framework under the Nebraska Medical Cannabis Patient Protection Act and Regulation Act but would not require the costs of cannabis to be covered by employers, insurance companies or workers’ comp...
...or chewed. Auvelity is expected to hit the market in Q4 of 2022. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
